Joel Greenblatt Gotham Asset Management
Joel Greenblatt is a co-founder of Gotham Asset Management and a well-known value investor, professor, and author. He gained wide recognition for The Little Book That Beats the Market and for popularizing a systematic value approach often called the “magic formula.” Greenblatt’s career spans special-situation investing, quantitative value strategies, and investor education.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$82.2M |
| 2 |
Conagra Brands
CAG
|
+$63.5M |
| 3 |
Intuit
INTU
|
+$53.2M |
| 4 |
PARA
Paramount Global Class B
PARA
|
+$51.9M |
| 5 |
CVS Health
CVS
|
+$43M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Instruments
TXN
|
+$40.5M |
| 2 |
Merck
MRK
|
+$39.5M |
| 3 |
DD
Du Pont De Nemours E I
DD
|
+$38.8M |
| 4 |
Viatris
VTRS
|
+$38.8M |
| 5 |
DaVita
DVA
|
+$37.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.31% |
| 2 | Industrials | 19.34% |
| 3 | Healthcare | 18.39% |
| 4 | Consumer Discretionary | 16.87% |
| 5 | Consumer Staples | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CAMP
826
DELISTED
CalAmp Corp.
CAMP
| $281K | ﹤0.01% |
824
-918
| -53% | -$323K |
|
827
Scansource
SCSC
$1.11B
| $275K | ﹤0.01% |
+7,415
| New | +$291K |
|
|
TCF
828
DELISTED
TCF Financial Corporation
TCF
| $273K | ﹤0.01% |
21,580
-2,122
| -9% | -$28.1K |
|
|
REGI
829
DELISTED
Renewable Energy Group, Inc.
REGI
| $269K | ﹤0.01% |
+30,464
| New | +$281K |
|
830
NRG Energy
NRG
$23.5B
| $268K | ﹤0.01% |
17,891
-499,511
| -97% | -$7.4M |
|
|
CORE
831
DELISTED
Core Mark Holding Co., Inc.
CORE
| $268K | ﹤0.01% |
5,727
-30,029
| -84% | -$1.27M |
|
|
RPXC
832
DELISTED
RPX Corporation
RPXC
| $267K | ﹤0.01% |
29,097
-4,223
| -13% | -$42.5K |
|
833
Kadant
KAI
$3.69B
| $266K | ﹤0.01% |
5,166
-4,150
| -45% | -$201K |
|
834
Interactive Brokers
IBKR
$42.3B
| $264K | ﹤0.01% |
+29,848
| New | +$285K |
|
835
John B. Sanfilippo & Son
JBSS
$882M
| $264K | ﹤0.01% |
6,200
-65,841
| -91% | -$3.59M |
|
836
Thermo Fisher Scientific
TMO
$230B
| $264K | ﹤0.01% |
1,790
-2,897
| -62% | -$428K |
|
|
ICON
837
DELISTED
Iconix Brand Group, Inc.
ICON
| $262K | ﹤0.01% |
3,882
+1,599
| +70% | +$125K |
|
|
LORL
838
DELISTED
Loral Space and Communications, Inc.
LORL
| $258K | ﹤0.01% |
7,306
-61,738
| -89% | -$2.24M |
|
|
K
839
DELISTED
Kellanova
K
| $257K | ﹤0.01% |
3,349
-219
| -6% | -$15.7K |
|
|
SPPI
840
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $257K | ﹤0.01% |
+39,070
| New | +$276K |
|
|
STR
841
DELISTED
QUESTAR CORP
STR
| $257K | ﹤0.01% |
+10,145
| New | +$254K |
|
|
AL
842
DELISTED
Air Lease Corp
AL
| $255K | ﹤0.01% |
+9,531
| New | +$284K |
|
843
Sherwin-Williams
SHW
$83.9B
| $254K | ﹤0.01% |
2,595
-6,747
| -72% | -$657K |
|
844
Supernus Pharmaceuticals
SUPN
$2.65B
| $254K | ﹤0.01% |
12,455
-5,097
| -29% | -$90.4K |
|
845
Global Payments
GPN
$25.1B
| $251K | ﹤0.01% |
+3,511
| New | +$259K |
|
846
BGC Group
BGC
$5.59B
| $247K | ﹤0.01% |
44,050
+423
| +1% | +$2.45K |
|
847
Allison Transmission
ALSN
$10.9B
| $245K | ﹤0.01% |
8,668
-4,904
| -36% | -$136K |
|
848
BioMarin Pharmaceuticals
BMRN
$12.6B
| $245K | ﹤0.01% |
+3,144
| New | +$267K |
|
849
Howard Hughes
HHH
$3.95B
| $245K | ﹤0.01% |
+2,245
| New | +$231K |
|
850
Capital One
COF
$133B
| $243K | ﹤0.01% |
+3,826
| New | +$266K |
|
Similar funds
Joel Greenblatt's Q2 2016 Portfolio in Review
As of Q2 2016, Joel Greenblatt held 1,194 positions worth $8.34B, down 6.5% from $8.92B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Joel Greenblatt withdrew a net $527M in Q2 2016, closing 260 positions and reducing 357 holdings. Its most notable exit was Viatris, an estimated $38.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Joel Greenblatt opened a new position in Twenty-First Century Fox, Inc. Class A worth $76.3M.
- Joel Greenblatt's largest Q2 2016 buy was Twenty-First Century Fox, Inc. Class A: 2,822,168 shares worth $76.3M.
- Joel Greenblatt added most to Paramount Global Class B in Q2 2016, an estimated $51.9M increase.
- Joel Greenblatt's biggest Q2 2016 reduction was Texas Instruments, cutting an estimated $40.5M.
- Joel Greenblatt fully exited Viatris in Q2 2016, selling an estimated $38.8M.
- Joel Greenblatt's ten largest holdings make up 9% of its $8.34B portfolio in Q2 2016.
- Joel Greenblatt opened 244 new positions and closed 260 in Q2 2016.
- Joel Greenblatt's portfolio value fell 6.5% quarter-over-quarter to $8.34B.
Based on Gotham Asset Management's 13F filing for Q2 2016, filed 15 Aug 2016.